基因合成市场规模、份额和成长分析（按方法、服务、应用、最终用途、地区）：产业预测（2024-2031）

2022年全球基因合成市场规模为21亿美元，从2023年的24.4亿美元成长到2031年的80.5亿美元，在预测期内（2024-2031年）预计复合年增长率为16.1%。

在有利的政府政策和不断增长的投资兴趣的推动下，合成生物市场正在经历显着增长。光是 2020 年，该产业就从政府和私人来源吸引了约 80 亿美元。 COVID-19 大流行加速了基因合成的机会，研究人员探索新的应用，包括开发合成 SARS-CoV-2 基因片段以增强诊断能力。随着合成 DNA 技术变得越来越普遍，它为新的病毒威胁和潜在的流行病提供了解决方案。此外，标靶治疗、免疫学和化疗的协同效应正在吸引生物技术和製药相关人员的关注，这预示着未来利润丰厚的商机。然而，这个市场面临着熟练专业人员短缺的挑战，公司正在与大学合作培训计划，以培养这一重要领域的人才。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 案例研究

全球基因合成市场规模/复合年增长率：依方法分类（2024-2031）

• 市场概况
• 固相合成
• 基于晶片的合成
• 基于PCR的酶合成

全球基因合成市场规模/复合年增长率：依服务分类（2024-2031）

• 市场概况
• 抗体DNA合成
• 病毒DNA合成
• 其他的

全球基因合成市场规模/复合年增长率：依应用分类（2024-2031）

• 市场概况
• 疫苗开发
• 治疗药物
• 诊断
• 研究与开发
  • 学术研究
  • 工业研究
• 合成生物学
  • 通路技术（通路技术）
  • 基因组工程

依最终用途分類的全球基因合成市场规模/复合年增长率（2024-2031）

• 市场概况
• 学术研究所
• 生物製药公司
• 合约研究组织（CRO）

全球基因合成市场规模/复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2023年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Thermo Fisher Scientific Inc. (GeneArt)
• GenScript Biotech Corporation
• Eurofins Genomics
• Integrated DNA Technologies (IDT)
• Twist Bioscience
• ATUM
• Bio Basic Inc.
• SBS Genetech Co. Ltd
• Azenta Life Sciences
• OriGene Technologies Inc.
• Bioneer Corporation
• Genewiz
• Blue Heron Biotech
• Creative Biogene
• SGI-DNA

结论和建议

Global Gene Synthesis Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.44 billion in 2023 to USD 8.05 billion by 2031, growing at a CAGR of 16.1% during the forecast period (2024-2031).

The synthetic biology market is experiencing significant growth, driven by favorable government policies and increased investment interest. In 2020 alone, the sector attracted approximately USD 8.0 billion from both government and private sources. The COVID-19 pandemic has accelerated opportunities within genetic synthesis, with researchers exploring novel applications, such as the development of synthetic SARS-CoV-2 gene segments to enhance diagnostic capabilities. As synthetic DNA technologies gain traction, they present solutions to emerging viral threats and potential pandemics. Furthermore, the synergy between targeted therapies, immunology, and chemotherapy is attracting attention from biotech and pharmaceutical stakeholders, indicating lucrative opportunities ahead. However, the market faces challenges due to a scarcity of skilled professionals, prompting companies to collaborate with universities for training initiatives to nurture talent in this critical sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Synthesis Market Segmental Analysis

Global Gene Synthesis Market is segmented by method, service, application, end use and region. Based on method, the market is segmented into solid-phase synthesis, chip-based synthesis and PCR-based enzyme synthesis. Based on service, the market is segmented into antibody DNA synthesis, viral DNA synthesis and others. Based on application, the market is segmented into vaccine development, therapeutics, diagnostics, research and development and synthetic biology. Based on end use, the market is segmented into academic and research institutes, biopharmaceutical companies and contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Synthesis Market

The global gene synthesis market is primarily driven by the increasing adoption of gene synthesis technologies across a multitude of research and development domains, such as molecular biology, synthetic biology, drug discovery, and genetic engineering. This innovative technology allows researchers to explore gene functions, create genetically modified organisms, devise new therapeutic solutions, and design novel biological systems. As the applications of gene synthesis expand within both academia and industry, its significance in driving scientific advancements becomes more pronounced, ultimately contributing to the growth of the market. The diverse utilization of gene synthesis in cutting-edge research significantly propels its demand.

Restraints in the Global Gene Synthesis Market

The Global Gene Synthesis market faces significant restraints primarily due to ethical and regulatory concerns. The potential for misuse of synthesized genes, which could lead to the creation of harmful pathogens or organisms, raises serious ethical questions. To mitigate these risks, various regulatory frameworks have been established, necessitating strict adherence to ethical guidelines and compliance mandates within the industry. However, these stringent regulations can also hinder market growth by complicating the processes required to obtain necessary approvals and licenses for certain applications. As a result, these challenges can create barriers that slow down innovation and development within the gene synthesis sector.

Market Trends of the Global Gene Synthesis Market

As of October 2023, the Global Gene Synthesis market is witnessing robust growth driven by the surging demand for gene editing and gene therapy technologies, especially with advancements like CRISPR-Cas9. The need for customized DNA constructs is becoming paramount in both experimental research and therapeutic applications, fueling the expansion of gene synthesis services. This intensified focus on precision medicine and genetic modifications is fostering innovation and collaboration among biotech firms, academic institutions, and healthcare providers. Consequently, the gene synthesis sector is positioned for a significant upturn, aligning with broader trends in molecular biology and personalized healthcare solutions globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Case Studies

Global Gene Synthesis Market Size by Method & CAGR (2024-2031)

• Market Overview
• Solid-Phase Synthesis
• Chip-Based Synthesis
• PCR-Based Enzyme Synthesis

Global Gene Synthesis Market Size by Service & CAGR (2024-2031)

• Market Overview
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Others

Global Gene Synthesis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Vaccine Development
• Therapeutics
• Diagnostics
• Research and Development
  • Academic Research
  • Industrial Research
• Synthetic Biology
  • Pathway Engineering
  • Genome Engineering

Global Gene Synthesis Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Academic and Research Institutes
• Biopharmaceutical Companies
• Contract Research Organizations (CROs)

Global Gene Synthesis Market Size & CAGR (2024-2031)

• North America (Method, Service, Application, End Use)
  • USA
  • Canada
• Europe (Method, Service, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Service, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Service, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Service, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc. (GeneArt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies (IDT)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATUM
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Basic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SBS Genetech Co. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioneer Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blue Heron Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGI-DNA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations